Oppenheimer analyst Jeff Jones downgraded Vascular Biogenics Ltd (NASDAQ: VBLT) from Outperform to Perform and removes its price target.The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE